Although PTEN functions as a tumor suppressor, and its increased expression is generally associated with the inhibition of cell proliferation via the PI3K/AKT signaling pathway, its regulation may not follow a linear or predictable pattern in all oncogenic contexts. This evidence concerns the gene AKT1 and neoplasm.